Eli Lilly and Company (NYSE: LLY) today announced that John C. Lechleiter, Ph.D., chairman, president and chief executive officer, will retire as president and CEO and from the company effective December 31, 2016. Lechleiter will remain non-executive chairman of Lilly's board of directors until May 31, 2017, at which time he will leave the board. Lilly's board of directors unanimously elected David A. Ricks, currently senior vice president and president, Lilly Bio-Medicines, to assume the role of president and chief executive officer and to join the board on January 1, 2017, and to become chairman of the board on June 1, 2017.

Eli Lilly and Company published this content on 27 July 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 27 July 2016 12:06:02 UTC.

Original documenthttps://investor.lilly.com/releasedetail.cfm?ReleaseID=981351

Public permalinkhttp://www.publicnow.com/view/C9BD5EBE6B0C63833AA78543F99554D872CC3D38